September 4, 2012Will make Prurisol for Phase II/III psoriasis trials
August 31, 2012Will pay $181 million to resolve claims
August 30, 2012Completes first phase of global network plan
August 30, 2012Provides GMP manufacturing services for research
August 30, 2012To develop and commercialize daratumumab
Gil Roth||August 29, 2012$17 mil. deal adds to endotoxin, microbial portfolio
August 29, 2012Analysis shows unlikely to meet efficacy endpoint
August 29, 2012Gains Aurangabad site from Orchid Chemicals
Gil Roth||August 28, 2012Expands PDX drug discovery models in oncology
Gil Roth||August 28, 2012Biomanufacturing deal covers global Phase II-III trials
August 24, 2012FV-100 Phase II results show promise
August 24, 2012Claris compliance issues resolved
August 23, 2012Will develop, manufacture, distribute and market generic drugs
August 23, 2012Enhances logistics operations
August 23, 2012Launches Prestium Pharma to manufacture and market in the U.S.
Sign up now to receive the free weekly newsletter, and more!
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.